An Evaluation of a Novel Dual Treponemal/Nontreponemal Point-of-Care Test for Syphilis as a Tool to Distinguish Active From Past Treated Infection
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Most syphilis point-of-care (POC) tests detect treponemal antibodies, which persist after successful treatment. Subsequent POC tests are positive, despite no active infection, and can lead to unnecessary treatment. We evaluated a new POC test, incorporating a nontreponemal component, to distinguish active from past infection. METHODS: Sera stored at 2 Australian laboratories were tested with DPP Screen and Confirm Assay. Treponemal and nontreponemal test lines were compared to corresponding conventional treponemal and nontreponemal reference test results: immunoassays and rapid plasma reagin (RPR), respectively, with RPR quantification by endpoint titration. POC test outcome concordance with conventional test results was assessed according to serological and clinical categories. RESULTS: Among 1005 serum samples tested, DPP treponemal line sensitivity was 89.8% (95% confidence interval [CI], 87.3%-91.9%) and specificity was 99.3% (95% CI, 97.0%-99.9%). DPP nontreponemal line sensitivity was 94.2% (95% CI, 91.8%-96.0%) and specificity was 62.2% (95% CI, 57.5%-66.6%). DPP test outcome (pair of test lines) was concordant with both reference test results for 94.3% of 404 high-titer infections, 90.1% of 121 low-titer infections, 27.5% of 211 past/treated infections, and 78.1% of 242 infections classified as not syphilis. Among 211 past/treated infections, 49.8% were incorrectly identified as active infection and a further 22.8% as not syphilis. CONCLUSIONS: DPP test use would result in identification of >93% of active syphilis infections, whereas just over half of past infections would be diagnosed as past or not syphilis, avoiding unnecessary treatment compared with other POC tests. This may be at the expense of missing some active infections; thus, its potential benefits will depend on the prevalence of past vs active infection in a population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis
Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.107623 · Cited by 634 · cited 1×
“36 million cases globally in 2008 [1], which can lead to fetal loss, perinatal death, prematurity, low birth weight, and a range of serious malformations in surviving children [2, 3].”
Newman, L., Kamb, M., Hawkes, S., Gomez, G., Say, L., Seuc, A., & Broutet, N. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001396 · Cited by 448 · cited 1×
“36 million cases globally in 2008 [1], which can lead to fetal loss, perinatal death, prematurity, low birth weight, and a range of serious malformations in surviving children [2, 3].”
BackgroundBlencowe, H., Cousens, S., Kamb, M., Berman, S., & Lawn, J. E. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-s3-s9 · Cited by 236
Hawkes, S., Matin, N., Broutet, N., & Low, N. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70104-9 · Cited by 204
Watson‐Jones, D., Gumodoka, B., Weiss, H., Changalucha, J., Todd, J., Mugeye, K., Buvé, A., Kanga, Z., Ndeki, L., Rusizoka, M., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/342951 · Cited by 172
Owusu-Edusei, K., Gift, T. L., & Ballard, R. C. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182260987 · Cited by 63
Cited by
Peeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
2020 European guideline on the management of syphilis
Janier, M., Unemo, M., Dupin, N., Tiplica, G. S., Potočnik, M., & Patel, R. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16946 · Cited by 421
Meta-analysis of ceftriaxone compared with penicillin for the treatment of syphilis
Liang, Z., Chen, Y.-P., Yang, C.-S., Guo, W., Jiang, X.-X., Xu, X.-F., Feng, S.-X., Liu, Y.-Q., & Jiang, G. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.020 · Cited by 44
Congenital Syphilis Prevention: Strategies, Evidence, and Future Directions
Plotzker, R. E., Murphy, R. D., & Stoltey, J. E. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000846 · Cited by 39
(2022) · doi:10.1136/sextrans-2022-055546 · Cited by 15
Self-citation
Metadata
- Authors
- Causer, L. M., Kaldor, J. M., Conway, D. P., Leslie, D. E., Denham, I., Karapanagiotidis, T., Ryan, C., Wand, H., Anderson, D. A., Robertson, P. W., McNulty, A. M., Donovan, B., Fairley, C. K., & Guy, R. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-03-25
- Volume
- 61
- Issue
- 2
- Pages
- 184-191
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2143110533
- Cited by
- 54
- References
- 6
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Evaluation of a Novel Dual Treponemal/Nontreponemal Point-of-Care Test for Syphilis as a Tool to Distinguish Active From Past Treated Infection. https://app.cochat.ai/papers/10.1093/cid/civ243
- The paper
- Causer, L. M., Kaldor, J. M., Conway, D. P., Leslie, D. E., Denham, I., Karapanagiotidis, T., Ryan, C., Wand, H., Anderson, D. A., Robertson, P. W., McNulty, A. M., Donovan, B., Fairley, C. K., & Guy, R. J. (2015). An Evaluation of a Novel Dual Treponemal/Nontreponemal Point-of-Care Test for Syphilis as a Tool to Distinguish Active From Past Treated Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/civ243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.